These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4353819)

  • 1. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages.
    Keller R
    J Exp Med; 1973 Sep; 138(3):625-44. PubMed ID: 4353819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors.
    Keller R
    Immunology; 1974 Aug; 27(2):285-98. PubMed ID: 4370655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of cellular proliferation and the generation of cytotoxic cells in an in vitro secondary immune response to syngeneic rat lymphoma cells.
    Bernstein ID; Cohen EF; Wright PW
    J Immunol; 1977 Mar; 118(3):1090-4. PubMed ID: 845434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxicity of peritoneal macrophages activated with Mycobacterium smegmatis.
    Yamamoto S; Tokunaga T
    Microbiol Immunol; 1978; 22(1):27-40. PubMed ID: 661626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumoristatic effects of nonimmune BALB/c peritoneal macrophages on syngeneic lymphoma cells in vitro.
    Li J; Mansfield M; Wallace JH
    Oncology; 1977; 34(6):245-50. PubMed ID: 593652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K
    J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
    Normann SJ; Cornelius J
    Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
    Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
    Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of target cell mitosis as a measure of the cytostatic effects of activated macrophages on tumor target cells.
    Krahenbuhl JL; Remington JS
    Cancer Res; 1977 Nov; 37(11):3912-6. PubMed ID: 908031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A; Lorinet AM; Thobie N; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic activity of in vitro generated macrophages: evidence for a prostaglandin-independent reversible cytostatic mechanism.
    Stout RD
    Cell Immunol; 1985 Nov; 96(1):83-103. PubMed ID: 2424622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells.
    Reed WP; Lucas ZJ
    J Immunol; 1975 Aug; 115(2):395-404. PubMed ID: 1097513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of tumor cell cytostasis by sea star factor-activated macrophages.
    Liu SH; McChesney MB; Prendergast RA
    Dev Comp Immunol; 1983; 7(3):545-54. PubMed ID: 6642046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of chemiluminescence during interaction of tumoricidal effector cell populations and tumor cells is dependent on the presence of mycoplasma.
    Köppel P; Peterhans E; Bertoni G; Keist R; Groscurth P; Wyler R; Keller R
    J Immunol; 1984 Apr; 132(4):2021-9. PubMed ID: 6607953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-operation between macrophages and a factor from lymphocytes in tumor lysis in vitro.
    Yamazaki M; Shinoda H; Mizuno D
    Gan; 1975 Oct; 66(5):489-97. PubMed ID: 1082827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
    Treves AJ; Schechter B; Cohen IR; Feldman M
    J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro tumor cell destruction by syngeneic mouse macrophoages: methods for assaying cytotoxicity.
    Norbury KC; Fidler IJ
    J Immunol Methods; 1975 Apr; 7(1):109-22. PubMed ID: 1123549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.